NEU 8.15% $13.27 neuren pharmaceuticals limited

Neuren Pharmaceuticals with Proactive at ASX Small and Mid-Cap Conference, page-78

  1. 2,169 Posts.
    lightbulb Created with Sketch. 572
    My preference also, licence out Nz-2591 similar to Acadia US deal, perhaps better terms and nice upfront!

    This would again have our partner do the heavy lifting, Neu just collect royalty/milestone revenue from all.

    10-15% from all sales from our pipeline would generate plenty of revenue for Neu based on recent Trof peak sales estimate and royalties, certainly give us share price $100-$150+

    This is a win for all holders and management, least work, enjoy the ride and collect the cash/divi’s

    This is exactly why should a TO be even considered it needs to be premium in my view!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.27
Change
1.000(8.15%)
Mkt cap ! $1.696B
Open High Low Value Volume
$12.95 $13.39 $12.79 $9.854M 751.2K

Buyers (Bids)

No. Vol. Price($)
3 2545 $13.26
 

Sellers (Offers)

Price($) Vol. No.
$13.29 1443 2
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.